Bank of New York Mellon Corp Raises Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Bank of New York Mellon Corp increased its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 18.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 613,330 shares of the company's stock after buying an additional 95,938 shares during the period. Bank of New York Mellon Corp owned about 1.23% of Nu Skin Enterprises worth $4,226,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in NUS. Rhumbline Advisers boosted its position in Nu Skin Enterprises by 70.9% during the fourth quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock worth $954,000 after purchasing an additional 57,443 shares during the period. Inspire Investing LLC boosted its position in shares of Nu Skin Enterprises by 7.8% in the fourth quarter. Inspire Investing LLC now owns 65,418 shares of the company's stock valued at $451,000 after acquiring an additional 4,728 shares during the period. Ballentine Partners LLC boosted its position in shares of Nu Skin Enterprises by 15.5% in the fourth quarter. Ballentine Partners LLC now owns 20,856 shares of the company's stock valued at $144,000 after acquiring an additional 2,800 shares during the period. Range Financial Group LLC bought a new position in shares of Nu Skin Enterprises in the fourth quarter valued at approximately $117,000. Finally, JPMorgan Chase & Co. boosted its position in shares of Nu Skin Enterprises by 175.6% in the third quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company's stock valued at $1,710,000 after acquiring an additional 147,784 shares during the period. Hedge funds and other institutional investors own 82.84% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of research firms have recently commented on NUS. DA Davidson cut their price objective on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a research report on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Tuesday, February 25th.

Nu Skin Enterprises Price Performance

Shares of NUS stock traded down $0.39 during trading hours on Friday, hitting $7.74. 2,275,500 shares of the company's stock were exchanged, compared to its average volume of 781,963. The company has a market capitalization of $384.61 million, a PE ratio of -2.62 and a beta of 1.06. Nu Skin Enterprises, Inc. has a 12-month low of $5.95 and a 12-month high of $14.04. The business's 50 day simple moving average is $7.34 and its 200-day simple moving average is $7.12. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.24 by $0.14. The firm had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. On average, equities research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 3.10%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -8.14%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.